Chimerix reported $1.43M in Sales Revenues for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Ardelyx ARDX:US $ 6.58M 4.77M
Chimerix CMRX:US $ 1.44M 0.32M
Curis CRIS:US $ 2.19M 0.84M
Dynavax Technologies DVAX:US $ 83.34M 63.78M
Emergent Biosolutions EBS:US $ 397.5M 54.5M
Epizyme EPZM:US $ 15.26M 6.89M
Gilead Sciences GILD:US $ 6217M 206M
Glaxosmithkline GSK:US $ 8092M 674M
Life Technologies LIFE:US $ 0M 2.05M
Merk MRK:US $ 11402M 678M
Mirati Therapeutics MRTX:US $ 0M 1.71M
Novavax NVAX:US $ 447.23M 167.57M
Xoma XOMA:US $ 375K 27.21M